Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid

被引:86
作者
Chiarugi, A [1 ]
Meli, E [1 ]
Moroni, F [1 ]
机构
[1] Univ Florence, Dipartimento Farmacol Preclin & Clin, I-50139 Florence, Italy
关键词
apoptosis; excitotoxicity; NMDA; poly-(ADP-ribose)-polymerase; tryptophan metabolism;
D O I
10.1046/j.1471-4159.2001.00335.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3OH-Kynurenine and quinolinic acid are tryptophan metabolites able to cause, at relatively elevated concentrations, neuronal death in vitro and in vivo. In primary cultures of mixed cortical cells, the minimal concentration of these compounds leading to a significant degree of;neurotoxicity decreased from 100 to 1 muM, when the exposure time was prolonged from 24 to 72 h. NMDA receptor antagonists and inhibitors of nitric oxide synthase or poly(ADP-ribose) polymerase reduced quinolinic acid, but not 3OH-kynurenine toxicity. In contrast, scavengers of free radicals, caspase inhibitors and cyclosporin preferentially reduced 3OH-kynurenine neurotoxicity. These observations suggest that quinolinic acid causes necrosis, whereas 3OH-kynurenine-exposed neurons primarily die in apoptosis, In line with this possibility, we found that ATP levels decreased more rapidly in quinolinate- than in 3OH-kynurenine-exposed cultures and that poly(ADP-ribose) polymer, the product of poly(ADP-ribose) polymerase activity, was more abundant in the nuclei of quinolinic acid than in those of 3OH-kynurenine-exposed neurons. Because minor changes in the physiological concentrations of 3OH-kynurenine and quinolinic acid may cause neuronal death, our data suggest that these metabolites play a key role in the pathogenesis of several neurological decisions.
引用
收藏
页码:1310 / 1318
页数:9
相关论文
共 51 条
[21]   RELATIONSHIP OF NEUROLOGIC STATUS IN MACAQUES INFECTED WITH THE SIMIAN IMMUNODEFICIENCY VIRUS TO CEREBROSPINAL-FLUID QUINOLINIC ACID AND KYNURENIC ACID [J].
HEYES, MP ;
JORDAN, EK ;
LEE, K ;
SAITO, K ;
FRANK, JA ;
SNOY, PJ ;
MARKEY, SP ;
GRAVELL, M .
BRAIN RESEARCH, 1992, 570 (1-2) :237-250
[22]   HUMAN MACROPHAGES CONVERT L-TRYPTOPHAN INTO THE NEUROTOXIN QUINOLINIC ACID [J].
HEYES, MP ;
SAITO, K ;
MARKEY, SP .
BIOCHEMICAL JOURNAL, 1992, 283 :633-635
[23]   Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types [J].
Heyes, MP ;
Chen, CY ;
Major, EO ;
Saito, K .
BIOCHEMICAL JOURNAL, 1997, 326 :351-356
[24]   Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques [J].
Heyes, MP ;
Saito, K ;
Lackner, A ;
Wiley, CA ;
Achim, CL ;
Markey, SP .
FASEB JOURNAL, 1998, 12 (10) :881-896
[25]   Interferon response heterogeneity:: activation of a pro-inflammatory response by interferonα and β.: A possible basis for diverse responses to interferonβ in MS [J].
Jansen, M ;
Reinhard, JF .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (04) :439-443
[26]   Neurocytotoxity of quinolinic acid in human brain cultures [J].
Kerr, SJ ;
Armati, PJ ;
Brew, BJ .
JOURNAL OF NEUROVIROLOGY, 1995, 1 (5-6) :375-380
[27]   Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex [J].
Kerr, SJ ;
Armati, PJ ;
Guillemin, GJ ;
Brew, BJ .
AIDS, 1998, 12 (04) :355-363
[28]  
KHO JY, 1995, SCIENCE, V268, P573
[29]   QUINOLINATE NEUROTOXICITY IN CORTICAL CELL-CULTURE [J].
KIM, JP ;
CHOI, DW .
NEUROSCIENCE, 1987, 23 (02) :423-432
[30]  
KOEHLER RC, 1988, NEUROSCIENCE, V7, P49